EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients‐A Population‐Based, Matched Case–Control Study

Keshet Pardo iD, Tasneem Kab, Mark A Hellmann, Itay Lotan iD, Tzippy Shochat, Nadav Loebl, Bar Yacobi, Yitzhak Friedman, Leor Perl, Nitai Shimon, Yiska Loewenberg Weisband, Liya Bieber und 2 weitere

Muscle & Nerve · 2026-06 · 73 (6) · 1016-1024

DOI: 10.1002/mus.70207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 07.03.2026. Verfasst von Keshet Pardo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Rabin Medical Center, Petach Tikva, Israel. Hauptthemen laut MEDLINE: Myasthenia Gravis, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Myasthenia gravis (MG) is associated with thymic neoplasms. However, an increased prevalence of extrathymic neoplasms has also been reported. This study aimed to evaluate the rates of malignancy in MG patients while accounting for risk factors such as disease characteristics and immunomodulatory treatments.

Methods

We conducted a case–control study using the Clalit Health Services database, applying a machine learning (ML) algorithm to minimize diagnosis misclassification. We included MG patients aged 18 years and older, with a sex‐ and age‐matched control group in a 1:3 ratio. We compared the prevalence and hazard ratios of extrathymic neoplasms between the groups.

Results

A total of 1558 patients with a high probability of MG, according to our ML model, were included in the cohort, alongside a control group of 4674 individuals. MG patients had a higher prevalence of malignancy prior to MG diagnosis, with an odds ratio of 1.95 (95% CI, 1.65–2.08), and a higher incidence of malignancy after MG diagnosis, with a hazard ratio of 1.56 (95% CI, 1.38–1.77). The most prevalent extrathymic neoplasms after MG diagnosis were respiratory, intrathoracic, skin (specifically non‐melanoma), urinary tract, soft tissue, and myelodysplastic syndrome. Risk factors for malignancy included age, male sex, and thymoma. Immunosuppressive treatment did not increase the risk of malignancy.

Discussion

MG patients have a higher prevalence of both solid and hematologic neoplasms compared to non‐myasthenic controls, regardless of immunosuppressive treatment. This supports the notion that malignancy is related to MG disease itself rather than external factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisNeoplasmsHumansMaleFemaleCase-Control StudiesMiddle AgedPrevalenceAgedAdultRisk FactorsYoung AdultAged, 80 and overMachine LearningAdolescent

Stichwörter der Autor:innen

artificial intelligenceextra‐thymic malignancymachine learningmalignancymyasthenia gravis

Autor:innen und Institutionen

  • Department of Neurology, Rabin Medical Center, Petach Tikva, Israel.
  • Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel.
  • Statistical Consultant, Rabin Medical Center, Petach Tikva, Israel.
  • Beilinson Medical Center Innovation, Artificial Intelligence Center, Rabin Medical Center, Petah Tikva, Israel.
  • Faculty of Computer Science, Reichman University, Herzliya, Israel.
  • Department of Cardiology, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

ORCID-Profile: Keshet Pardo, Itay Lotan, Eitan Auriel, Adi Wilf-Yarkoni

Zitieren

APA

Pardo, K., Kab, T., Hellmann, M. A., Lotan, I., Shochat, T., Loebl, N., Yacobi, B., Friedman, Y., Perl, L., Shimon, N., Weisband, Y. L., Bieber, L., Auriel, E., & Wilf-Yarkoni, A. (2026). Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients‐A Population‐Based, Matched Case–Control Study. Muscle & Nerve, 73(6), 1016-1024. https://doi.org/10.1002/mus.70207

Vancouver

Pardo K, Kab T, Hellmann MA, Lotan I, Shochat T, Loebl N, et al. Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients‐A Population‐Based, Matched Case–Control Study. Muscle & Nerve. 2026;73(6):1016-1024. doi:10.1002/mus.70207

BibTeX
@article{Pardo2026,
  author = {Pardo, Keshet and Kab, Tasneem and Hellmann, Mark A and Lotan, Itay and Shochat, Tzippy and Loebl, Nadav and Yacobi, Bar and Friedman, Yitzhak and Perl, Leor and Shimon, Nitai and Weisband, Yiska Loewenberg and Bieber, Liya and Auriel, Eitan and Wilf-Yarkoni, Adi},
  title = {Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients‐A Population‐Based, Matched Case–Control Study},
  journal = {Muscle & Nerve},
  year = {2026},
  volume = {73},
  number = {6},
  pages = {1016--1024},
  doi = {10.1002/mus.70207}
}
Kostenlos starten →